G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 08, 2020 at 01:05 pm EST
Share
G&E Herbal Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 9.769 million compared to TWD 5.114 million a year ago. Operating loss was TWD 4.182 million compared to TWD 6.169 million a year ago. Net loss was TWD 3.363 million compared to TWD 5.957 million a year ago. Basic loss per share was TWD 0.06 compared to TWD 0.11 a year ago. For the nine months, sales was TWD 18.916 million compared to TWD 12.652 million a year ago. Operating loss was TWD 13.680 million compared to TWD 21.082 million a year ago. Net loss was TWD 12.406 million compared to TWD 20.180 million a year ago. Basic loss per share was TWD 0.22 compared to TWD 0.36 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
